Here you can find studies currently accepting participants in Australia.
Click on the study names for more information. If you are interested in participating in a study, please contact that study directly.
Are you interested in future research projects? Join our email list and we will send you an email as soon as a new study is added to this page.
Study NameStudy FocusStudy AimState(s)Who can participate?Allergy Status
PEBBLESPreventionTo find out if infant skin management with a particular cream, called EpiCeram™, might help reduce the chances that a child will develop allergiesVICInfants, aged 0-3 weeks (expressions of interest from pregnant women welcome)Baby to have family history of allergy
OPTIMUMPreventionTo investigate if giving a dose of 'whole-cell' whooping cough vaccine between 6 and 12 weeks of age, instead of the 'acellular' whooping cough vaccine can help protect against allergyWAInfants, aged 6-12 weeksAll welcome
OPIATreatmentTo determine whether graded peanut ingestion along with a dietary fibre supplement can train the body to become tolerant to peanut in children with peanut allergyACT, NSWChildren/Adolescents, aged 10-16 years Food allergy – peanut
VITALITYPreventionTo assess whether vitamin D supplementation during infancy can prevent food allergy in the first year of lifeVICInfants, aged 6-12 weeksAll welcome
SYMBAPreventionTo determine whether maternal prebiotic supplementation during pregnancy and breastfeeding can reduce the development of eczema in babiesWAPregnant women, less than 21 weeks gestationBaby to have family history of allergy
PrEggNutPreventionTo test whether the amount of eggs and peanuts a mother eats during pregnancy and breastfeeding has an influence on her baby’s food allergy developmentNow: WA, SA, VIC
Planned: NSW
Pregnant women, less than 23 weeks gestationBaby to have family history of allergy
PEATTreatmentTo test the hypothesis that probiotic and egg OIT is more effective than placebo at inducing sustained unresponsiveness (remission) in participants with egg allergy 8 weeks after end-of-treatmentVICChildren/Adolescents, aged 5-17 yearsFood allergy – egg
EPITOPETreatmentTo evaluate the safety and efficacy of a novel desensitisation method, called EPicutaneous ImmunoTherapy (EPIT) with the Viaskin® Peanut patch in young childrenNow: NSW - Westmead, QLD, SA, VIC, WA
Planned: NSW - Randwick
Children, aged 1-3 yearsFood allergy – peanut
Families: Join our email list to receive an email alert each time a new study is added to this page. 
Researchers: Please contact us to add your currently recruiting study to this page.

Last modified: October 16th 2019 | Date created: May 28th 2019